参考文献/References:
[1] 王飞,陈姝.脑血疏口服液辅助治疗急性缺血性脑卒中临床研究[J].新中医,2021,53(20):50-53.
[2] Alper BS, Foster G, Thabane L, et al. Thrombolysis with alteplase 3-4.5 hours after acute ischaemic stroke: trial reanalysis adjusted for baseline imbalances[J]. BMJ Evid Based Med, 2020, 25(5): 168-171.
[3] 张文,董斌,席春华.远隔缺血处理在急性缺血性卒中患者的应用[J].国际脑血管病杂志,2021,29(5):370-377.
[4] Ajoolabady A, Wang S, Kroemer G, et al.Targeting autophagy in ischemic stroke:From molecular mechanisms to clinical therapeutics[Z],2021:107848.
[5] 房裕钞,王黎洲,黄学卿,等.微小RNA-155通过Notch信号通路对脑缺血-再灌注损伤的影响[J].介入放射学杂志,2019,28(7):661-668.
[6] 金强,刘冬,刁玉刚,等.κ阿片受体激动剂U45088 H对大鼠体外循环后认知功能及PKA-CREB信号通路影响[J].临床军医杂志,2020,48(2):133-136.
[7] Herpich F, Rincon F. Management of acute ischemic stroke[J]. Crit Care Med, 2020, 48(11): 1654-1663.
[8] Rabinstein AA. Update on treatment of acute ischemic stroke[J]. Continuum(Minneap Minn), 2020, 26(2): 268-286.
[9] 鲍宏刚,苏芳菊,徐志勇,等.κ阿片受体选择性激动剂U50488H对大鼠心房纤维化及缝隙连接蛋白43重构的影响[J].现代生物医学进展,2020,20(10):1824-1828, 1888.
[10] 朱金,杜宇平.丁苯酞软胶囊联合双联抗血小板治疗急性缺血性脑卒中疗效及对血清β2-MG HCY CysC和神经功能的影响[J].河北医学,2021,27(10):1734-1739.
[11] Fan J, Li L, Qu P, et al. κ opioid receptor agonist U50488H attenuates postoperative cognitive dysfunction of cardiopulmonary bypass rats through the PI3K/AKT/Nrf2/HO-1 pathway[J]. Mol Med Rep, 2021, 23(4): 293.
[12] 曾芳芳,余丽红,王丽君.穴位贴敷与针刺联合常规疗法治疗缺血性脑卒中后失眠临床研究[J].新中医,2021,53(20):156-160.
[13] 丁俊云,陈维英,王震虹,等.salvinorin A上调MALAT1表达减轻缺血性脑卒中大鼠的脑血管内皮损伤[J].国际麻醉学与复苏杂志,2020,41(12):1124-1130.
[14] Lamark T, Svenning S, Johansen T. Regulation of selective autophagy: the p62/SQSTM1 paradigm[J]. Essays Biochem, 2017, 61(6): 609-624.
[15] 周大旺,张晨禹,黎博,等.转录因子EB通过激活自噬及溶酶体功能改善缺血性卒中小鼠神经功能[J].中国病理生理杂志,2021,37(7):1178-1186.
[16] 李鲁博.尼莫地平对缺血性脑卒中自噬相关蛋白Beclin1、LC3表达的影响[D].镇江:江苏大学,2018.
[17] Wang H, Zang C, Liu XS, et al. The role of Notch receptors in transcriptional regulation[J]. J Cell Physiol, 2015, 230(5): 982-988.
[18] 田会玲,李庆盟,孙新月,等.中医药对缺血性脑卒中神经修复中Notch信号通路的调控机制研究进展[J].世界中西医结合杂志,2017,12(10):1477-1480.
[19] Maida CD, Norrito RL, Daidone M, et al. Neuroinflammatory mechanisms in ischemic stroke: focus on cardioembolic stroke, background, and therapeutic approaches[J]. Int J Mol Sci, 2020, 21(18): 6454.
[20] 温艺超,陈伟燕,谢富华,等.DAPT阻断Notch通路对动脉粥样硬化型缺血性脑卒中大鼠的保护作用[J].中国病理生理杂志,2018,34(11):2031-2036.
相似文献/References:
[1]高敏,张亚琼,芮海杰,等.内蒙古地区蒙古族与汉族血浆同型半胱氨酸水平差异及分析[J].卒中与神经疾病杂志,2015,22(01):47.
[2]杨新林,李月春,李锐铭,等.脑血管储备功能的临床应用进展[J].卒中与神经疾病杂志,2015,22(01):50.
[3]王本孝.脑微出血的研究进展[J].卒中与神经疾病杂志,2015,22(01):52.
[4]曹阳月,朱雨岚.脑缺血后处理与PI3K/Akt信号转导通路的研究进展[J].卒中与神经疾病杂志,2015,22(03):192.
[5]解晓睿,刘煜敏,和珂莉,等.中国人群脂联素+45位点基因单核苷酸多态性与缺血性脑卒中易感性的Meta分析[J].卒中与神经疾病杂志,2014,21(06):361.
[6]曹炳华,乔振虎.缺血性脑卒中患者血清SIRT1水平与早期神经功能恶化的相关性研究[J].卒中与神经疾病杂志,2022,29(04):330.[doi:10.3969/j.issn.1007-0478.2022.04.005]
Cao Binghua,Qiao Zhenhu..Correlation between serum SIRT1 and early neurological deterioration of patients with ischemic stroke[J].Stroke and Nervous Diseases,2022,29(04):330.[doi:10.3969/j.issn.1007-0478.2022.04.005]
[7]何妮,易兴阳.CYP2C8,GPIIIa和P2Y12变异体之间的相互作用增加了缺血性脑卒中的易感性[J].卒中与神经疾病杂志,2022,29(04):359.[doi:10.3969/j.issn.1007-0478.2022.04.011]
[8]何涛,索志超,孔德强,等.术前血清CTRP3,CTRP9水平与缺血性脑卒中患者颈动脉支架成形术后再狭窄的相关性研究[J].卒中与神经疾病杂志,2022,29(05):427.[doi:10.3969/j.issn.1007-0478.2022.05.006]
e Tao*,Suo Zhichao,Kong Deqiang*,et al.Correlation between preoperative serum CTRP3, CTRP9 levels and restenosis after carotid artery stenting in patients with cerebral ischemic stroke[J].Stroke and Nervous Diseases,2022,29(04):427.[doi:10.3969/j.issn.1007-0478.2022.05.006]
[9]林夏妃,吴海霞,史静琴,等.呼吸肌训练经皮质-膈肌通路对缺血性脑卒中患者的作用机制分析[J].卒中与神经疾病杂志,2022,29(05):442.[doi:10.3969/j.issn.1007-0478.2022.05.009]
Lin Xiafei,Wu Haixia,Shi Jingqin,et al.Mechanism of respiratory muscle training via cortical diaphragm pathway in patients with ischemic stroke[J].Stroke and Nervous Diseases,2022,29(04):442.[doi:10.3969/j.issn.1007-0478.2022.05.009]
[10]宋秀威 杨月君 王伟.五味子乙素调节MAPK/NF-κB/AP-1信号通路对缺血性脑卒中大鼠神经元损伤的影响[J].卒中与神经疾病杂志,2023,30(03):242.[doi:10.3969/j.issn.1007-0478.2023.03.002]
Song Xiuwei*,Yang Yuejun,Wang Wei..Schisandrin B attenuates neuronal damage in rats with ischemic stroke by regulating MAPK/NF-κB/AP-1 signaling pathway[J].Stroke and Nervous Diseases,2023,30(04):242.[doi:10.3969/j.issn.1007-0478.2023.03.002]